✦ LIBER ✦

The Potential for Medical Therapy to Reduce the Risk of Colorectal Cancer and Optimize Surveillance in Inflammatory Bowel Disease

✍ Scribed by Chapman, Christopher G.; Rubin, David T.

Book ID: 122262803
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 278 KB
Volume: 24
Category: Article
ISSN: 1052-5157
DOI: 10.1016/j.giec.2014.03.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5-Aminosalicylic acid therapy and the ri

5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease

✍ Jonathan P. Terdiman; Michael Steinbuch; William A. Blumentals; Thomas A. Ullman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

## Background: Patients with inflammatory bowel disease (ibd) affecting the colon are at increased risk of developing colorectal cancer (crc). published data are conflicting about whether 5-aminosalicylic acid (5-asa) has chemopreventive properties against ibd-related carcinogenesis. the objective

Potential danger in the medical use of T

Potential danger in the medical use of Trichuris suis for the treatment of inflammatory bowel disease

✍ Herbert J Van Kruiningen; A Brian West 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB

255 Aminosalicylates, Thiopurines and th

255 Aminosalicylates, Thiopurines and the Risk of Colorectal Cancer in Inflammatory Bowel Diseases: A Case-Control Study Nested in the CESAME Cohort

✍ Fabrice Carrat; Philippe Seksik; Anne-Marie Bouvier; Nicole Brousse; Franck Carb 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Telomerase and tert for the detection of

Telomerase and tert for the detection of colorectal cancer in inflammatory bowel disease: The usefulness of telomerase in colonoscopic washings

📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 105 KB

What should be the standard of care for

What should be the standard of care for cancer surveillance, diagnosis of dysplasia, and the decision for colectomy in chronic inflammatory bowel disease?

✍ Perry Hookman; Jamie S Barkin 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 54 KB

622 Risk of Subsequent Cancer Under Immu

622 Risk of Subsequent Cancer Under Immunosuppressive Therapy in Patients With Inflammatory Bowel Disease and Prior Cancer: Data From the CESAME Prospective Observational Cohort

✍ Laurent Beaugerie; Fabrice Carrat; Jean-Baptiste Chevaux; Harry Sokol; Laurent P 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 118 KB